The peer-reviewed results, by a team of researchers at McMaster University in Ontario, were published online Wednesday by the scientific journal Nature. They could help doctors quickly test and treat unusual clotting, which results from a mixture of immune clotting and loss of platelets that stops the bleeding.

WHO urges treatment for Covid-19 with anti-inflammatory drugs from Roche and Sanofi

The World Health Organization has recommended that some hospitalized Covid-19 patients receive a type of anti-inflammatory that reduces the risk of death by 13% in sickest patients when taken in combination with steroids .

The global public health agency updated its Covid-19 treatment guidelines on Tuesday to strongly recommend that people with severe or critical illness receive drugs tocilizumab and sarilumab to fight the hackneyed inflammatory immune response in some patients .

Pfizer vaccine less effective against Delta infections but prevents serious illness, Israeli data shows

TEL AVIV-Data from Israel suggests that Pfizer Inc.’s vaccine is less effective in protecting against infections caused by the Delta variant of Covid-19, but retains its potency in preventing serious illnesses caused by the highly contagious strain.

The vaccine protected 64% of those vaccinated against infection during an outbreak of the Delta variant, up from 94% previously, according to Israel’s health ministry. It was 94% effective at preventing serious illness during the same period, up from 97% previously, the ministry said.

Aon dealt a blow in submitting a speedy lawsuit over the US Willis Towers merger challenge

WASHINGTON – Federal judge said he could not schedule a summer trial in the Justice Department’s antitrust lawsuit challenging insurance broker Aon PLC’s proposed acquisition of rival Willis Towers Watson PLC , a blow to Aon’s offer to save a deal that expires on September 9.

Instead, U.S. District Judge Reggie Walton said on Tuesday he planned to hold a trial for a few days starting Nov. 18 and then again during a Dec. 20-22 opening of his schedule. A decision could take weeks or months after these procedures are completed.

World’s first Covid-19 vaccine swap sends expiring supplies from Israel to South Korea

Israel has sent around 700,000 expiring Pfizer-BioNTech injections to South Korea, in what is the world’s first Covid-19 vaccine swap.

South Korea, which received only 20% of the 192 million doses it pre-ordered, will later return an identical number of doses to Israel. The arrangement is likely to be considered by other governments, according to health experts.

WORLD NEWS

Glynn’s take: the RBA will eventually wake up to a rapid labor market tightening

The Reserve Bank of Australia expects it to be among the last of the world’s major central banks to begin the task of scaling back and possibly exiting its bond buying program, before it begins to normalize interest rates.

RBA Governor Philip Lowe’s argument that the central bank will drag its feet is based on the idea that wage growth and inflation outcomes in Australia have lagged other economies for many years. years, so the task of restoring order in the country is greater.

China’s regulatory measures hit Chinese tech stocks

Chinese tech stocks fell on Tuesday after China’s cybersecurity regulator broadened its review of several of the country’s newest state-owned companies.

Rideshare giant Didi Global Inc. has lost nearly a third of its value since the shares hit $ 18 each on June 30, the day the company made public debut. Chinese authorities last week banned the company from adding new users and launched an investigation into the company’s data practices.

Bitcoin Fraud Problems Grab Regulators’ Attention

Regulators are signaling they want more control over a larger cryptocurrency universe that has pushed Wall Street business further without the investor and consumer protections that apply to traditional securities and financial services.

The catch: No regulator inspects crypto exchanges or brokers, unlike securities and derivatives markets. Regulators only step in when they believe U.S. law applies to a particular cryptocurrency or transaction, depending on how the asset was sold or traded.

China targets overseas listed companies after Didi Probe launch

China said it would tighten rules for companies listed overseas or seeking to sell shares overseas, measures that could hamper attempts by local firms to raise funds in the United States.

The change comes as Chinese regulators are stepping up scrutiny of tech companies, including recently-listed Didi Global Inc. in the United States.

Write to [email protected]

Write to us at [email protected]

We offer an enhanced version of this briefing that is optimized for viewing on mobile devices and sent directly to your inbox. If you would like to register, go to https://newsplus.wsj.com/subscriptions.

This article is a text version of a Wall Street Journal newsletter published earlier today.

(END) Dow Jones Newswires

July 07, 2021 06:00 ET (10:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.